National antibiotic program in the Czech Republic NAP-CZ Vlastimil Jindrák and Subcommitte for antibiotic policy ČLS JEP.

Slides:



Advertisements
Similar presentations
February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
Advertisements

Management of Drug Formulary Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 06/16/06.
Medication Management
1 Health Care Reform in Hong Kong - Department of Health ’ s Perspective Dr Constance Chan Assistant Director of Health May 2001.
Performance Improvement Leadership Develop Program
ACCESS TO MENTAL HEALTH CARE IN ROMANIA Adina BITFOI M.D., Psychiatrist Romanian League for Mental Health.
G aps, challenges and opportunities Theo Verheij University Medical Center Utrecht Lower Respiratory Tract Infections in Primary Care.
TRAINING FOR ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN HOSPITALS JUNE 2014.
THE FRAMEWORK FOR A NEW PUBLIC HEALTH STRATEGY FOR THE REPUBLIC OF SERBIA Prof. Dr Snežana Simić School of Medicine Belgrade University Serbia and Montenegro.
STRAMA A 10 year perspective Swedish Strategic programme for the Rational use of Antimicrobial Agents and Surveillance of Resistance
Antimicrobial resistance “One health fits all”
PORTUGUESE HEALTH PROFILE EUMAPH/ETC PH-HP 7 th Masters on Public Health National School of Public Health 2004 A HEALTH PROMOTION PERSPECTIVE.
Implementation of a Hospital Paediatric Antimicrobial Stewardship Program Sydney Children’s Hospital Mostaghim M, Snelling T, McMullan B, Palasanthiran.
Essential Drugs Programme
1 Drug and Therapeutics Committee Session 10. Standard Treatment Guidelines.
Model regulations on demand reduction in Europe Bylaw on drug demand reduction.
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre & Beaumont Hospital, Dublin, Ireland HPSC, SARI and National HCAI.
Hans Wolf-Watz, professor, UCMR, MIMS, Department of Microbiology, Umeå University, Sweden, Antibiotic resistance a new.
WHO local pilot projects to contain AMR ICIUM 2004 K.A.Holloway and T.L.Sorensen Essential Drugs and Medicines Policy WHO Geneva.
Key Strategies for Improving Use of Existing and New Antibiotics -the European Experience Otto Cars Professor Inf. Diseases, Uppsala University, Sweden.
Briefing on 4th Meeting of Antimicrobial Resistance National Focal Points Ljubljana (Slovenia), 13 March 2008 Dominique L. Monnet Senior Expert, Antimicrobial.
Recommendation on prudent use of antimicrobial agents in human medicine – Slovenian experiences Intersectoral Coordination Mechanism Prof. Milan Čižman,
The Swedish Experience Otto Cars Prof. Infectious Diseases Uppsala University Hospital Sweden.
Presentation WG 2 Managing EU Funds on the Regional Level Republic of Albania Ministry of European Integration (MEI) Regional Conference EU Perspectives.
October 17, 2011 Innovation strategy and its implementation in the Czech Republic.
DETERMINE an EU Consortium for Action on the socio-economic determinants of health Dorothee Heinen Federal Centre for Health Education, BZgA Reducing Health.
Towards a European network for digital preservation Ideas for a proposal Mariella Guercio, University of Urbino.
10/22/2015 AER Social Politics & Public Health Committee 2, Katowice ( Slaskie, PL ) A REVIEW OF THE HEALTH SYSTEM IN ROMANIA
An International Conference that Examines the Issues of Yesterday, the Challenges of Today, and the Opportunities for Tomorrow SARS: Crisis and Opportunity.
MINISTRY OF HEALTH OF THE REPUBLIC OF BELARUS THE REPUBLICAN RESEARCH PRACTICAL CENTER FOR EPIDEMIOLOGY AND MICROBIOLOGY AMR SURVEILLANCE IN THE REPUBLIC.
CHAZ Public Private Partnership in PBF Public Private Partnership in PBF Church State Collaboration) Presentation to the PBF Multi-Country Conference In.
Strategy and Policy Cohesion: “The One Health Agenda: will it deliver” Elizabeth J. Phillips, MD, FRCPC,FRACP, FACTM Professor & Director, Centre for Clinical.
Land Governance and Security of Tenure in Developing Countries White paper of the French Development cooperation LAND POLICIES AND MDGS IN RESPONSE TO.
Volservnet Voluntary Services and Networking A project in collaboration with the Ministry of Health, the Elderly and Community Care.
Healthy Ageing: Citizens needs and expectation The challenge for society CONCLUSIONS Bad Gastein, October 2003.
Annual Meeting of the ASADI – Science Academies as Partners for Improving the Impact of Policies in Africa Session V: Partnership Themes for Development.
English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Figures Slideset.
MEDICATION MANAGEMENT P&T COMMITTEE AND FORMULARY MANAGEMENT EMTENAN ALHARBI, Msc CLINICAL PHARMACIST.
Programme Operators Meeting Programme CZ11 Public Health Initiatives Context of the Programme CZ 11 related to the health strategies in the Czech Republic.
CDERA The Caribbean Disaster Emergency Response Agency INSTITUTIONAL CAPACITY/REFORM Presentation by Mr Jeremy Collymore Coordinator, Caribbean Disaster.
EHFG 7 October 2005 – Patient Safety & Research UK Presidency Workshop on Patient Safety, EHFG, Bad Hofgastein,7 September 2005 Kevin McCarthy, European.
Single Competency Framework for Prescribers National Prescribing Centre (2012)
European Centre for Disease Prevention and Control
Perspectives on containing antimicrobial resistance – ways to go … Karl Ekdahl, Strategic Advisor on behalf of Zsuzsanna Jakab, Director European Centre.
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,
Ministerial Declaration and Concluding Remarks MD PhD Karin Tegmark Wisell Chair AMR expert group, NDPHS.
Antibiotic resistance: National actions contribute to a global solution NEPAL Professor Paras K Pokharel Vice Chair GARP Nepal.
Országos Epidemiológiai Központ National Center for Epidemiology, Budapest, Hungary Activities in Hungary for preventing AMR and controlling HCAI Emese.
National Information Day Greece 23 July 2015 Funding priorities under the work plan 2015.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
Global health A research priority at the UoB. At the University of Bergen.. Development related research, including Global Health is –An important field.
Primary health care Dr. Hassan M. Alnuaimy Msc. Orthodontics.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
1. SUSTAINABLE ANIMAL PRODUCTION The future of the farmers 2.
An Audit to Determine if Prescribers are Reviewing Antimicrobial Prescriptions Hours After Initiation. Natalie Holman, Emma Cramp, Joy Baruah Hinchingbrooke.
Knowledge for welfare and health National Research and Development Centre for Welfare and Health International Development Collaboration1 Social inclusion.
Prescribing of antibiotics in Slovenia in the period 1999 – 2015 Jurij Fürst ZZZS Slovenia 21 th EUMASS Congress and 4 th Congress of Medical Assessors.
Antimicrobial Resistance in Poland - a state of affairs and prevention Danuta O. Lis the Ministry of Health, Poland 11th NDPHS PAC side event, 19th November.
1 The contribution of VICH to the global One Health approach VICH5 CONFERENCE, OCTOBER 2015, TOKYO Jean-Pierre Orand, Anses, France, OIE Collaborating.
Convening today at TIFR, Mumbai on 29th January, 2017, on the occasion of the Tata Memorial Centre Platinum Jubilee Conference – ‘Healthcare – a commodity.
Antibiotics: handle with care!
Declaration of the 11th ministerial-level PAC meeting in Berlin 2015 From strategies to action – how to tackle the challenges of Antimicrobial Resistance.
Hospital Antibiotic Stewardship Programs
Strategy and Policy Cohesion: “The One Health Agenda: will it deliver”
Essential Drugs and Medicines Policy
Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.
Essential Drugs and Medicines Policy
European recommendations for antimicrobial resistance surveillance
Presentation transcript:

National antibiotic program in the Czech Republic NAP-CZ Vlastimil Jindrák and Subcommitte for antibiotic policy ČLS JEP

EU Conference - Brdo - Slovenia2 Milestones of NAP-CZ… 1970 – 75Establishing Antibiotic Centres 1990Establishing Working Group for AMR surveillance 1997Subcommittee for antibiotic policy (co-ordinating group) 2001 – 02Preparatory working group for NAP-CZ in MoH 2003Basic document of NAP-CZ, Committee in MoH 2003 – 04Quality projects focused on AMR 2005WHO country visit: recommendations to MoH 2005NAP Action plan – NAP Action plan – , WHO-ECDC co-operation 2006Committee in MoH cancelled 2007Negotiations SKAP – MoH: New model of NAP 2008MoH decision: New model of NAP 2008AMR: priority for future EU Presidency of CZ

EU Conference - Brdo - Slovenia3 Subcommittee for Antibiotic Policy (SKAP) structure of the Czech Medical Association J.E.Purkyně SKAP structure interdisciplinary and intersectoral principle, confirmation of membership by professional societies SKAP activities opponency and guarantee by professional societies, acceptation by presidium ČLS JEP microbiology, epidemiology pharmacology, pharmacy infectious diseases paediatrics general practice intern. med. (chemotherapy) veterinary medicine SKAP guidelines – therapy, prophylaxis guidelines – ATB consensus guidelines – AMR control AP organization, ATB centers action plans, interventions internat. co-operation, projects co-operation with veterinarians

EU Conference - Brdo - Slovenia4 Intersectoral Coordination Mechanism Local levelNational level Antibiotic centres Working groups Veterinary antibiotic centres National Antibiotic Programme co-ordinating group Ministry of Health Ministry of Agriculture Subcommitte on ATB Policy Czech Medical Association Professional Societies National Institute of Public Health State Veterinary Administration

EU Conference - Brdo - Slovenia5 Antibiotic centers basic operating units of NAP-CZ

EU Conference - Brdo - Slovenia6 Activities of antibiotic centers Local surveillance of AMR in hospitals and community Local surveillance of ATB use in hospitals and community Consulting antibiotic use Improving quality of antibiotic use – local interventions Categorisation of antibiotics (restricted drugs) Preparation and updating local guidelines Education

EU Conference - Brdo - Slovenia7 Antibiotic consumption in the Czech Republic trends in ambulatory consumption DDD/1000/day (1989) 19 DDD/1000/day (1999)

EU Conference - Brdo - Slovenia8 Intervention in primary paediatric care (ATB consumption – ESAC) repeated, multicentric ATB prescribing audit intervention in primary paediatric care

EU Conference - Brdo - Slovenia9 Resistance S.pneumoniae in Europe - EARSS-2005 penicillin

EU Conference - Brdo - Slovenia10 Resistance S.pyogenes to erythromycine in CZ trend 1996 – 2005, data NRL for antibiotics intervention in primary paediatric care

EU Conference - Brdo - Slovenia11 Invasive MRSA in CZ hospitals trend in 2000 – 2005 (EARSS data) 4.3 %5.9 % 6.1 %8.5 %12.9 %

EU Conference - Brdo - Slovenia12 Klebsiella pneumoniae – EARSS 2005 resistance to 3 rd generation cephalosporins

EU Conference - Brdo - Slovenia13 AMR problems in CZ hospitals Potential reasons for increasing trend Lack of systematic interventions for improving ATB use (auditing, feed-back for prescribers and consultants…) Sub-optimal hospital infection control programmes (lack of capacities for isolation, missing infection control nurses…) Performance-oriented hospital care, de-motivating economic feed-back, sub-optimal organisation of intensive care Influence of pharmaceutical industry Need for innovation of local ATB stewardship programmes Need for improvement of local infection control programmes

EU Conference - Brdo - Slovenia14 National antibiotic program – Czech experience Conditions for future developments, benefits and efficiency Wide activities realised on the voluntary basis are not sustainable in long-term perspective and decline efficiency Support of government is essential for successful NAP activities at the national level The role of government consists in creating sufficient conditions for complex professional activities (realizing action plans), not in direct management of NAP by state Organizational structures of low vulnerability by political changes are necessary for long lasting stability, continuity and efficiency of NAP